Literature DB >> 2736204

Melphalan transport into human malignant lymphoid cells differs from the murine equivalent in vitro.

B C Millar1, J A Maitland, J L Millar, J B Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2736204      PMCID： PMC2247227          DOI： 10.1038/bjc.1989.149

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  13 in total

1.  CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

Authors:  G E FOLEY; H LAZARUS; S FARBER; B G UZMAN; B A BOONE; R E MCCARTHY
Journal:  Cancer       Date:  1965-04       Impact factor: 6.860

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's Hospital studies.

Authors:  P Selby; G Zulian; G Forgeson; A Nandi; S Milan; M Meldrum; C Viner; R Osborne; J S Malpas; T J McElwain
Journal:  Hematol Oncol       Date:  1988 Apr-Jun       Impact factor: 5.271

4.  Evidence for active transport of melphalan by two amino acid carriers in L5178Y lymphoblasts in vitro.

Authors:  A Begleiter; H Y Lam; J Grover; E Froese; G J Goldenberg
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

5.  Comparison of melphalan toxicity in human lymphocytic cells and Chinese hamster cells in vitro: the relationship between DNA-DNA cross-link formation and clonogenic survival.

Authors:  B C Millar; J B Bell
Journal:  Carcinogenesis       Date:  1987-09       Impact factor: 4.944

6.  Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells.

Authors:  M Dufour; L C Panasci; J St Germain; L Boulet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

7.  High-dose intravenous melphalan for plasma-cell leukaemia and myeloma.

Authors:  T J McElwain; R L Powles
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

8.  Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell.

Authors:  D T Vistica
Journal:  Biochim Biophys Acta       Date:  1979-01-19

9.  A simple method for culturing myeloma cells from human bone marrow aspirates and peripheral blood in vitro.

Authors:  B C Millar; J B Bell; A Lakhani; M J Ayliffe; P J Selby; T J McElwain
Journal:  Br J Haematol       Date:  1988-06       Impact factor: 6.998

10.  Activation of murine 'T' lymphomas in the presence of a human myeloma cell line, RPMI-8226, in vivo.

Authors:  B C Millar; J L Millar; A Jones; S W Feary; D Robertson; J B Bell
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.